Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 285 participants.

Also called NCT01983449

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 285 participants (enrolled count) (from the registry)
Sponsor
Mercator MedSystems, Inc. (from the registry)
Registry
  • NCT NCT01983449
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01983449. Allocation not applicable; no masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Acronym
DANCE
Condition
Peripheral Arterial Diseases
Intervention (Drug)
Dexamethasone Sodium Phosphate Injection, USP
Lead sponsor
Mercator MedSystems, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01983449
Content hash
3326b6fedd5566021c6874a73fec93931be4ae183ee4d74bc017de6596df0d83